Lonza walkersville, INC.:1110291 [12-006523]
Ended Awarded Last action
- Contract number
- HHSN26800001
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $713,046
Award facts
- Contract value 100% obligated
- $713,046.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $298,646 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $414,400 |
About this award
This delivery order, awarded to Lonza Walkersville, Inc. on September 18, 2012, carries a ceiling value of $713,046 and represents a firm fixed-price contract with the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health. The contract, which operated through September 16, 2017, was awarded without a set-aside designation, indicating open competition. Performance of work occurs at Lonza Walkersville's facility in Walkersville, Maryland. As a foreign-owned, for-profit manufacturer specializing in biological materials and laboratory equipment, Lonza Walkersville supplies high-precision research products including cell culture media, specialized cell lines, and advanced scientific instrumentation to federal biomedical research institutions.
This delivery order falls under the larger "Gene Insertion - Pluripotent Stem Cells 2012-2017" master Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The work supports NHLBI's research initiatives, leveraging Lonza Walkersville's established capabilities as a critical supplier to multiple NIH institutes and the Food and Drug Administration. The company's expertise in cell processing devices, transfection systems, and cell culture media directly supports the institute's research needs in cardiovascular and pulmonary science, aligning with NHLBI's mission to advance heart, lung, and blood research and improve public health outcomes.
Quick answers
Who was awarded contract HHSN26800001?
HHSN26800001 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on September 18, 2012.
How much is contract HHSN26800001 worth?
The government has obligated $713,046 on HHSN26800001.
Which agency awarded contract HHSN26800001?
Office of the Director (National Institutes of Health) awarded HHSN26800001, with funding from National Heart Lung and Blood Institute (National Institutes of Health).
Is contract HHSN26800001 an order under another contract?
Yes. HHSN26800001 is a delivery order under HHSN268201200011I, an indefinite delivery contract, on Gene Insertion - Pluripotent Stem Cells 2012-2017.
Was contract HHSN26800001 competed?
The extent of competition for HHSN26800001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award